Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy
- 1 March 2004
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 8 (3) , 227-232
- https://doi.org/10.1016/j.gassur.2003.11.024
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapySurgery, 2002
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- Predictive factors for success of neo‐adjuvant therapy in upper gastrointestinal cancerJournal of Gastroenterology and Hepatology, 2002
- Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.2001
- Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinomaCancer, 2001
- Does neoadjuvant chemoradiation downstage esophageal carcinoma?The American Journal of Surgery, 2001
- Analysis of Reduced Death and Complication Rates After Esophageal ResectionAnnals of Surgery, 2001
- Treatment of Esophageal CarcinomaChest, 1999
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- Multimodal treatment for squamous cell esophageal cancerWorld Journal of Surgery, 1995